Cullinan Therapeutics Inc (CGEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 168,198 | 63,250 | N/A | N/A |
| Marketable Securities | 42,008 | 35,380 | N/A | N/A |
| TOTAL | $212,278 | $100,091 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 130 | 182 | N/A | N/A |
| Other Non-Current Assets | 2,300 | 188 | 0 | 0 |
| TOTAL | $2,430 | $370 | $N/A | $N/A |
| Total Assets | $214,708 | $100,461 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 9,679 | 934 | 0 | 0 |
| Accrued Expenses | 4,641 | 1,589 | N/A | N/A |
| TOTAL | $14,320 | $2,523 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 7,733 | 138,844 | 0 | 0 |
| TOTAL | $74 | $137,847 | $N/A | $N/A |
| Total Liabilities | $14,394 | $140,370 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 3 | 0 | N/A | N/A |
| Retained earnings | -93,339 | -41,540 | N/A | N/A |
| Other shareholders' equity | 1,302 | 861 | 0 | 0 |
| TOTAL | $200,314 | $-39,909 | $N/A | $N/A |
| Total Liabilities And Equity | $214,708 | $100,461 | $0 | $0 |